Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Change in Inventory came in at -$703861.0 in Q1 2026, up 27.24% year-on-year from -$553167.6 in Q1 2025, and down 441.7% quarter-over-quarter from $205989.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Change in Inventory (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Change in Inventory across 17 years of filings, most recently posting -$703861.0 for Q1 2026.
- Change in Inventory for Q1 2026 came in at -$703861.0, up 27.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (up 38.26% YoY), and the FY2025 annual result was -$2.2 million, up 6.88% from the prior year.
- Change in Inventory came in at -$703861.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $205989.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.6 million in Q3 2022 to a low of -$2.3 million in Q1 2022.
- The 5-year median for Change in Inventory is -$630409.0 (2025), against an average of -$367224.1.
- Across the five-year window, Change in Inventory surged 756.09% in 2022 and sank 1073.11% in 2024, its largest moves.
- Cumberland Pharmaceuticals' Change in Inventory stood at $427803.0 in 2022, then grew by 3.2% to $441498.0 in 2023, then tumbled by 402.63% to -$1.3 million in 2024, then surged by 115.42% to $205989.0 in 2025, then plunged by 441.7% to -$703861.0 in 2026.
- The last three Change in Inventory figures came in at -$703861.0 (Q1 2026), $205989.0 (Q4 2025), and -$630409.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn | -703,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -703,861.00 |
| Mar 31, 2026 | -703,861.00 |
| Dec 31, 2025 | 205,989.00 |
| Dec 31, 2025 | 205,989.00 |
| Sep 30, 2025 | -630,409.00 |
| Sep 30, 2025 | -630,409.00 |
| Jun 30, 2025 | -850,797.00 |
| Jun 30, 2025 | -850,797.00 |
| Mar 31, 2025 | -967,399.00 |
| Mar 31, 2025 | -967,399.00 |
| Dec 31, 2024 | -1.34 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | 170,950.00 |
| Sep 30, 2024 | 170,950.00 |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | -170,469.00 |
| Mar 31, 2024 | -170,469.00 |
| Dec 31, 2023 | 441,498.00 |
| Dec 31, 2023 | 441,498.00 |